Photo taken from
Benjamin Toll/X
Jun 8, 2024, 07:23
Benjamin Toll: Interesting study about nausea prevention with olanzapine
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on X/Twitter:
“Interesting study in Journal of Clinical Oncology ASCO about nausea prevention with olanzapine
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial | Journal of Clinical Oncology.”
Read further.
Source: Benjamin Toll/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19